Skip to main content

Posts

Showing posts with the label USA gene therapy market

Gene Therapy Market will reach about USD 5.55 billion by 2026|Novartis, Gilead Sciences

April 18, 2019:  The global gene therapy market size is expected to reach USD 5.55 billion by 2026, growing at a CAGR of 33.9% over the forecast period, according to a new report by Radiant Insights, Inc. Gene therapy is being developed with an aim to identify and cure rare conditions, diseases that have limited treatment options and that need lifelong medication to keep the symptoms in check. For instance, metabolic disorders like lysosomal diseases need constant medical attention with the medication available now, however, gene therapy might become a one-time cure to such diseases. To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/gene-therapy-market/request-sample There are a number of molecules under development due to intense competition. This factor is projected to be the key factor propelling the market growth. In early 2018, there were more than 950 molecules in the pipeline with various regulatory bodies in various clinical phases....